What is the risk associated with LVAD patients?

• A. Low risk of infection and no bleeding
• B. Only risk is device malfunction
• C. Increased risk of infection, stroke, STEMI, arrhythmias, and bleeding
• D. Decreased risk of infection

Answer: (C)

LVAD therapy saves heart function but creates a complex risk profile that touches multiple systems. The device requires lifelong anticoagulation to prevent pump thrombosis, which raises the chance of bleeding, including serious GI or intracranial bleeds, while the high-shear environment can cause acquired von Willebrand syndrome that worsens bleeding tendencies. The driveline and implanted hardware provide a foothold for infection, from the exit site to device-related sepsis. The presence of a foreign device and altered blood flow also elevates the risk of thromboembolic events and stroke. Arrhythmias are common in these patients due to changes in ventricular mechanics and interactions with the device. Underlying coronary disease and the patient’s critical cardiac state keep the possibility of myocardial infarction, including STEMI, on the table. Because this option captures the broad, interrelated set of risks associated with LVADs, it represents the best answer.